发表研究结果有使用 ab13890?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab13890 被引用在 6 文献中.

  • Luan Z  et al. Rocaglamide overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase-8 through cellular FLICE-like-inhibitory protein downregulation. Mol Med Rep 11:203-11 (2015). WB ; Human . PubMed: 25333816
  • Oh Y  et al. Regulation in the targeting of TRAIL receptor 1 to cell surface via GODZ for TRAIL sensitivity in tumor cells. Cell Death Differ 19:1196-207 (2012). PubMed: 22240897
  • Choi H  et al. Peroxiredoxin 6 interferes with TRAIL-induced death-inducing signaling complex formation by binding to death effector domain caspase. Cell Death Differ 18:405-14 (2011). WB ; Human . PubMed: 20829884
  • Fan S  et al. Scatter factor protects tumor cells against apoptosis caused by TRAIL. Anticancer Drugs 21:10-24 (2010). PubMed: 19823077
  • Ishdorj G  et al. Inhibition of Constitutive Activation of STAT3 by Curcurbitacin-I (JSI-124) Sensitized Human B-Leukemia Cells to Apoptosis. Mol Cancer Ther 9:3302-14 (2010). WB ; Human . PubMed: 21159613
  • Mendoza FJ  et al. Death receptor-4 (DR4) expression is regulated by transcription factor NF-kappaB in response to etoposide treatment. Apoptosis 13:756-70 (2008). WB ; Human . PubMed: 18421578

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"